NEW ORLEANS -- In an interview at the Society of Nuclear Medicine and Molecular Imaging annual meeting, Phillip Kuo, MD, PhD, of the City of Hope in Duarte, CA, discussed new appropriate use criteria for amyloid and tau PET imaging in Alzheimer’s disease patients.
Video from SNMMI: Phillip Kuo on new Alzheimer’s disease imaging guidelines
Latest in Molecular Imaging
PSMA-PET visualizes treatment response in liver cancer
November 6, 2025
Sirona gets FDA nod for advanced imaging suite
October 30, 2025
Global initiative to guide NMTs in theranostics
October 29, 2025



















